Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System.
Sign Up to like & getrecommendations! Published in 2020 at "Investigative Radiology"
DOI: 10.1097/rli.0000000000000624
Abstract: OBJECTIVES The aim of this study was to determine a safe and effective dose of gadopiclenol, a new high relaxivity macrocyclic gadolinium-based contrast agent. Based on the contrast-to-noise ratio (CNR) as primary criterion, this new… read more here.
Keywords: gadopiclenol gadobenate; gadobenate dimeglumine; dimeglumine; study ... See more keywords
Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis.
Sign Up to like & getrecommendations! Published in 2020 at "Radiology"
DOI: 10.1148/radiol.2020190246
Abstract: Background Increased cerebral signal intensity (SI) has been reported in patients undergoing MRI with gadolinium-based contrast agents (GBCAs). Published data on gadobenate dimeglumine have been somewhat contradictory. Purpose To evaluate the relationship between dosage of… read more here.
Keywords: dentate nucleus; gadobenate dimeglumine; dimeglumine; dimeglumine administrations ... See more keywords
A case of gadobenate dimeglumine-induced anaphylactic shock: a case report.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of palliative medicine"
DOI: 10.21037/apm-21-1076
Abstract: A 70-year-old man was admitted to our hospital due to "liver cirrhosis; grade 3 hypertension; pulmonary infection". On May 27, 2019, during upper abdomen plain and enhanced magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography… read more here.
Keywords: gadobenate dimeglumine; anaphylactic shock; dimeglumine; case ... See more keywords